z-logo
open-access-imgOpen Access
SF1126, a Pan-PI3K Inhibitor has Potent Pre-Clinical Activity in Aggressive B-Cell Non-Hodgkin Lymphomas by Inducing Cell Cycle Arrest and Apoptosis
Author(s) -
Wenqing Qi,
A Stejskal,
Carla Morales,
Laurence Cooke,
Joseph R. Garlich,
Donald L. Durden,
Daruka Mahadevan
Publication year - 2012
Publication title -
journal of cancer science and therapy
Language(s) - English
Resource type - Journals
ISSN - 1948-5956
DOI - 10.4172/1948-5956.1000143
Subject(s) - apoptosis , cell cycle checkpoint , cell cycle , cancer research , b cell , pi3k/akt/mtor pathway , medicine , cell , lymphoma , biology , pharmacology , immunology , genetics , antibody

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here